CytoSorbents Corporation (CTSO)

[caesare74]

Burnttoast: since Fresenius Medical is a well known and successfull global operating company, thru their well established local networks they will faster achieve reimbursment codes than CTSO alone. One of their key advantage is the fact that they have the headoffice in Germany. Their focus is Asia where they have an easier access with CTSO than in the US. Korea is the trigger market for Asia.
I'm very confident since Asia regulation authorities are much more solution oriented than in the USA. As we all know the FDA is very complex and slow. Further, FDA is much more influenced by big pharma than in Asia, mainly China + Japan.